Effective sensitization of temozolomide by ABT-888 is lost with development of temozolomide resistance in glioblastoma xenograft lines.
在胶质母细胞瘤异种移植细胞系中，随着替莫唑胺耐药性的产生，ABT-888 对替莫唑胺的有效增敏作用也随之丧失
期刊:Molecular Cancer Therapeutics
影响因子:5.5
doi:10.1158/1535-7163.MCT-08-0854
Clarke Michelle J, Mulligan Evan A, Grogan Patrick T, Mladek Ann C, Carlson Brett L, Schroeder Mark A, Curtin Nicola J, Lou Zhenkun, Decker Paul A, Wu Wenting, Plummer E Ruth, Sarkaria Jann N
